Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bernard Testa is active.

Publication


Featured researches published by Bernard Testa.


Archive | 1993

3D Modelling of soybean glyoxysomal malate dehydrogenase

Nicolas Guex; François Widmer; Patrick Gaillard; Pierre-Alain Carrupt; Bernard Testa

Introduction: The enzyme malate dehydrogenase, which is present in various subcellar locations such as cytoplasm (cMDH), mitochondria (mMDH), glyoxysomes (gMDH), peroxisomes and chloroplasts, catalyses the oxidation of malate into oxaloacetate using NAD+/NADP+ as cofactor. The primary structure of soybean gMDH has been determined from sequencing data of severa! eDNA, clones (isolated from a library constructed with mRNA from 3-day-old cotyledons). In order to predict the effect of mutations on the activity or specificity of this enzyme, we built up its 3D structure starting from data obtained with crystallized isozymes. Results and Discussion: From the Brookhaven Protein Database, it appears that only the pig cytoplasmic MDH (cMDH) structure has been solved with an acceptable resolution. Despite the low identity (26%) between pig cMDH and soybean gMDH, we used the former as a template for the 3D modelling of soybean gMDH. Using the BioPolymer module of the SYBYL Software together with the Amber force field and Pullman partial atomic charges, a 3D madel of gMDH is proposed. Soybean gMDH was first aligned onto water melon gMDH, water melon mMDH and pig mMDH, which was possible without introducing gaps. Pig cMDH (starting point of the 3D modelling) was aligned onto the former enzymes using the conserved amino acids with pig mMDH as anchor points, while the rest of the sequence was aligned manually and with the help of computer programs to maximise the number of similar amino acids and to minimize the number of gaps. After this alignment, the 3D structure of pig cMDH was progressively changed to soybean gMDH by modifications of the side chains, by elimination or insertion of amino acids, and by preparing Ioops. Local geometry optimizations were conducted for most of these changes. Final optimizations were conducted in the absence or presence of NAD+ and/or substrate (i.e., malate), allowing comparison of the active site with respect to those of related enzymes (pig cMDH, dogfish LDH). The conservation of shape and functionality of the active site was quite impressive and can be used to propose a slight revision of amino acids involved in malate binding as suggested previously. Our computer model of soybean gMDH identified three amino acids which are directly involved in the binding of malate: Arg87, Arg159 and Ser229. In pig cMDH the corresponding Arg91, Arg 161 and Ser240 bind malate together with a fourth amino acid (Ser 241). This Ser residue is not conserved in other MDHs. The lack of this H-bond would not significantly affect the binding of malate, as Ser241 only adds a fourth H-bond to the malate carbonyl group which is already tightly bound to Arg161 (Arg 159 in gMDH).


Archive | 2001

Pharmacokinetic optimization in drug research

Bernard Testa; H van der Waterbeemd; Gerd Folkers; Richard H. Guy; H van de Waterbeemd


Archive | 1997

Computer-Assisted Lead Finding and Optimization

Han van de Waterbeemd; Bernard Testa; Gerd Folkers


Molecular Pharmacology | 1986

The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.

Gavin J. Kilpatrick; N. El Tayar; H. Van De Waterbeemd; P Jenner; Bernard Testa; C. D. Marsden


Advances in drug research | 1987

The parametrization of lipophilicity and other structural properties in drug design

H. Van De Waterbeemd; Bernard Testa


Archive | 1996

Lipophilicity in Drug Action and Toxicology: Pliška/Lipophilicity

Vladimir Pliška; Bernard Testa; Han van de Waterbeemd


Biochemical Journal | 1995

Mechanism of ligand binding to alpha 1-acid glycoprotein (orosomucoid): correlated thermodynamic factors and molecular parameters of polarity.

Saïk Urien; Y. Giroud; Ruey-Shiuan Tsai; Pierre-Alain Carrupt; Françoise Brée; Bernard Testa; Jean-Paul Tillement


European Journal of Medicinal Chemistry | 1985

L-DOPA esters as potential prodrugs. I: Physicochemical properties

C. Marrel; G. Boss; H. Van De Waterbeemd; Bernard Testa; D. Cooper; P Jenner; C. D. Marsden


Archive | 2007

ADME-Tox approaches

Bernard Testa; Han van de Waterbeemd


Archive | 1993

Multivariate data modeling of new steric, topological and CoMFA-derived substituent parameters

Han van de Waterbeemd; Pierre-Alain Carrupt; Bernard Testa; Lemont B. Kier

Collaboration


Dive into the Bernard Testa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

P Jenner

Medical Research Council

View shared research outputs
Top Co-Authors

Avatar

L. Anker

University of Lausanne

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

N. El Tayar

University of Lausanne

View shared research outputs
Top Co-Authors

Avatar

Nicolas Guex

Swiss Institute of Bioinformatics

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge